<html class="fa-events-icons-failed" lang="en" xmlns="https://www.w3.org/1999/xhtml"><head>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<meta content="text/html; charset=utf-8" http-equiv="content-type"/>
<meta content="origin-when-cross-origin" name="referrer"/>
<title>Cannabis for Inflammatory Bowel Disease - Full Text View - ClinicalTrials.gov</title>
<link href="https://clinicaltrials.gov/ct2/show/NCT01040910" rel="canonical"/>
<meta content="article" property="og:type"/>
<meta content="Cannabis for Inflammatory Bowel Disease - Full Text View - ClinicalTrials.gov" property="og:title"/>
<meta content="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-logo.png" property="og:image"/>
<meta content="Cannabis for Inflammatory Bowel Disease - Full Text View." property="og:description"/>
<meta content="https://clinicaltrials.gov/ct2/show/NCT01040910" property="og:url"/>
<link href="https://clinicaltrials.gov/ct2/html/images/favicon.ico" rel="shortcut icon"/>
<link href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon-144x144.png" rel="apple-touch-icon-precomposed" sizes="144x144"/>
<link href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon-114x114.png" rel="apple-touch-icon-precomposed" sizes="114x114"/>
<link href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon-72x72.png" rel="apple-touch-icon-precomposed" sizes="72x72"/>
<link href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon-precomposed.png" rel="apple-touch-icon-precomposed"/>
<link href="https://clinicaltrials.gov/ct2/html/images/apple-touch-icon.png" rel="apple-touch-icon-precomposed"/>
<link href="https://clinicaltrials.gov/ct2/html/jquery/css/superfish.css?v=27" media="screen" rel="stylesheet" type="text/css"/>
<link href="https://clinicaltrials.gov/ct2/html/css/glossary.css?v=27" rel="stylesheet" type="text/css"/>
<link href="https://clinicaltrials.gov/ct2/html/css/base.css?v=27" rel="stylesheet" type="text/css"/>
<link href="https://clinicaltrials.gov/ct2/html/css/print.css?v=27" media="print" rel="stylesheet" type="text/css"/>
<link href="https://clinicaltrials.gov/ct2/html/css/w3-ct.css?v=27" rel="stylesheet" type="text/css"/>
<!--[if lt IE 9]>
	<link rel="stylesheet" href="/ct2/html/css/w3-ct-oldIE.css?v=27" type="text/css" />
  <![endif]-->
<script src="https://use.fontawesome.com/20a31629ec.js"></script><link href="https://use.fontawesome.com/20a31629ec.css" media="all" rel="stylesheet"/>
<!--[if lte IE 7]>
       <link href="/ct2/html/css/target-IE7-and-below.css" rel="stylesheet" type="text/css">
<![endif]-->
<style type="text/css">
  h2 
  {
      background-color: #EAEAEA;
  }
</style>
<link href="https://clinicaltrials.gov/ct2/html/css/trial-record.css?v=27" rel="stylesheet" type="text/css"/>
<script src="https://clinicaltrials.gov/ct2/html/jquery/js/jquery.min.js?v=27" type="text/javascript"></script><noscript></noscript>
<script src="https://clinicaltrials.gov/ct2/html/jquery/js/superclick.js?v=27" type="text/javascript"></script><noscript></noscript>
<script src="https://clinicaltrials.gov/ct2/html/jquery/js/jquery.cookie.js?v=27" type="text/javascript"></script><noscript></noscript>
<script src="https://clinicaltrials.gov/ct2/html/js/ct.js?v=27" type="text/javascript"></script><noscript></noscript>
<script src="https://clinicaltrials.gov/ct2/html/js/ctmenu.js?v=27" type="text/javascript"></script><noscript></noscript>
<script type="text/javascript">
$(window).on('load', function(){
    loadCTCommon();
    });
</script><noscript></noscript>
<script>
var theURL = "/ct2/show/NCT01040910"+window.location.hash;
history.replaceState(null,null,theURL);
</script>
<script type="text/javascript">
    ncbi_pingWithImage=true;
    __ncbi_stat_url="//www.ncbi.nlm.nih.gov/stat";        
  </script>
<meta content="86156550d2af4356_14efdfSID" name="ncbi_sid"/>
<meta content="ctgov" name="ncbi_app"/>
<meta content="ctgov" name="ncbi_db"/>
<meta content="show_study" name="ncbi_pdid"/>
<meta content="NCT01040910" name="ncbi_pcid"/>
<meta content="RRf05kx5" name="ncbi_ctreqid"/>
<meta content="SRf04pTw" name="ncbi_ctsessid"/>
<meta content="IsbmLRaW" name="ncbi_ctipid"/>
<meta content="wp1" name="ncbi_cthost"/>
<style media="print" type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('//www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=ctgov&ncbi_db=ctgov&ncbi_pcid=NCT01040910&ncbi_pdid=show_study&ncbi_phid=86156550d2af43591563096123598SID'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style></head>
<body class="js ct-one-column">
<script type="text/javascript">
(function(){var g=function(e,h,f,g){
this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null};
this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "};
this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0};
this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g+ "&t=" + (new Date()).getTime();document.body&&document.body.appendChild(a)}};
this.start=function(){var a=this;window.addEventListener?window.addEventListener("load",function(){a.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){a.go()})}};
try{(new g(100,"r","QSI_S_ZN_7WHWRcRMBs9xWYd","https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd")).start()}catch(i){}})();
</script><div id="ZN_7WHWRcRMBs9xWYd"></div>
<div aria-describedby="glossary-result" aria-hidden="true" class="glossary" id="glossary">
<button class="js-glossary-close button button--close js-glossary-toggle usa-button-unstyled" tabindex="-1" title="Close glossary"><span class="usa-sr-only">Hide glossary</span>
<i aria-hidden="true" class="fa fa-times"></i>
</button>
<h4 class="glossary-heading">Glossary</h4>
<p>
  Study record managers: refer to the <a href="https://clinicaltrials.gov/ct2/manage-recs/resources#DataElement" tabindex="-1"><u>Data Element Definitions</u></a> if submitting registration or results information.
  </p>
<p>
<label class="label" for="glossary-search">Search for terms</label>
</p>
<span class="clearable-input">
<input class="js-glossary-search" id="glossary-search" tabindex="-1"/>
<span class="js-glossary-clear button js-glossary-toggle usa-button-unstyled" data-clear-input="">x</span>
</span>
<div class="glossary__content" id="glossary-result">
<ul class="js-glossary-list"><li class="glossary__item"><button aria-controls="glossary-content-0" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Accepts healthy volunteers</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-0" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="Show definition">eligibility criteria</span> that indicates whether people who do not have the <span class="term" data-term="condition/disease" tabindex="-1" title="Show definition">condition/disease</span> being studied can participate in that clinical study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-1" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Active comparator arm</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-1" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="Show definition">arm type</span> in which a group of participants receives an <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span> considered to be effective (or active) by health care providers.</div></li><li class="glossary__item"><button aria-controls="glossary-content-2" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Adverse event</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-2" style="display: none;">An unfavorable change in the health of a participant, including abnormal laboratory findings, that happens during a clinical study or within a certain amount of time after the study has ended. This change may or may not be caused by the <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span> being studied.</div></li><li class="glossary__item"><button aria-controls="glossary-content-3" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Age or age group</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-3" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="Show definition">eligibility criteria</span> that indicates the age a person must be to participate in a clinical study. This may be indicated by a specific age or the following age groups:<p>The age groups are: </p><ul><li>Child (birth-17)</li><li>Adult (18-64)</li><li style="margin-bottom:-.4em;">Older Adult (65+)</li></ul></div></li><li class="glossary__item"><button aria-controls="glossary-content-4" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">All-cause mortality</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-4" style="display: none;">A measure of all deaths, due to any cause, that occur during a clinical study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-5" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Allocation</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-5" style="display: none;">A method used to assign participants to an arm of a clinical study. The types of allocation are <span class="term" data-term="randomized allocation" tabindex="-1" title="Show definition">randomized allocation</span> and nonrandomized.</div></li><li class="glossary__item"><button aria-controls="glossary-content-6" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Arm</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-6" style="display: none;">A group or subgroup of participants in a clinical trial that receives a specific <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span>, or no intervention, according to the trial's <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-7" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Arm type</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-7" style="display: none;">A general description of the clinical trial arm. It identifies the role of the intervention that participants receive. Types of arms include <span class="term" data-term="experimental arm" tabindex="-1" title="Show definition">experimental arm</span>, <span class="term" data-term="active comparator arm" tabindex="-1" title="Show definition">active comparator arm</span>, <span class="term" data-term="placebo comparator arm" tabindex="-1" title="Show definition">placebo comparator arm</span>, <span class="term" data-term="sham comparator arm" tabindex="-1" title="Show definition">sham comparator arm</span>, and <span class="term" data-term="no intervention arm" tabindex="-1" title="Show definition">no intervention arm</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-8" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Baseline characteristics</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-8" style="display: none;">Data collected at the beginning of a clinical study for all participants and for each arm or comparison group. These data include demographics, such as age, sex/gender, race and ethnicity, and study-specific measures (for example, systolic blood pressure, prior antidepressant treatment).</div></li><li class="glossary__item"><button aria-controls="glossary-content-9" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Canceled submission</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-9" style="display: none;">Indicates that the study sponsor or investigator recalled a submission of <span class="term" data-term="study results" tabindex="-1" title="Show definition">study results</span> before <span class="term" data-term="quality control (qc) review" tabindex="-1" title="Show definition">quality control (QC) review</span> took place. If the submission was canceled on or after May 8, 2018, the date is shown. After submission of study results, a <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> cannot be modified until QC review is completed, unless the submission is canceled.</div></li><li class="glossary__item"><button aria-controls="glossary-content-10" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Certain agreements</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-10" style="display: none;">Information required by the <span class="term" data-term="food and drug administration amendments act of 2007, section 801 (fdaaa 801)" tabindex="-1" title="Show definition">Food and Drug Administration Amendments Act of 2007</span>. In general, this is a description of any agreement between the sponsor of a clinical study and the <span class="term" data-term="principal investigator (pi)" tabindex="-1" title="Show definition">principal investigator</span> (PI) that does not allow the PI to discuss the results of the study or publish the study results in a scientific or academic journal after the study is completed.</div></li><li class="glossary__item"><button aria-controls="glossary-content-11" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Certification</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-11" style="display: none;">A sponsor or investigator may submit a certification to delay submission of results information if they are applying for FDA approval of a new drug or device, or new use of an already approved drug or device. A sponsor or investigator who submits a certification can delay results submission up to 2 years after the <span class="term" data-term="certification/extension first submitted" tabindex="-1" title="Show definition">certification/extension first submitted</span> date, unless certain events occur sooner. See <a href="https://prsinfo.clinicaltrials.gov/results_definitions.html#DelayResultsType" style="text-decoration:underline dotted" tabindex="-1" target="_blank">Delay Results Type</a> in the Results Data Element definitions for more information about this certification.</div></li><li class="glossary__item"><button aria-controls="glossary-content-12" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Certification/extension first posted</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-12" style="display: none;">The date on which information about a <span class="term" data-term="certification" tabindex="-1" title="Show definition">certification</span> to delay submission of results or an <span class="term" data-term="extension request" tabindex="-1" title="Show definition">extension request</span> was first available on ClinicalTrials.gov. ClinicalTrials.gov does not indicate whether the submission was a certification or extension request. There is typically a delay between the date the study sponsor or investigator submitted the certification or extension request and the <span class="term" data-term="first posted" tabindex="-1" title="Show definition">first posted date</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-13" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Certification/extension first submitted</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-13" style="display: none;">The date on which the study sponsor or investigator first submitted a <span class="term" data-term="certification" tabindex="-1" title="Show definition">certification</span> or an <span class="term" data-term="extension request" tabindex="-1" title="Show definition">extension request</span> to delay submission of results. A sponsor or investigator who submits a certification can delay results submission up to 2 years after this date, unless certain events occur sooner. There is typically a delay between the date the certification or extension request was submitted and the date the information is first available on ClinicalTrials.gov (<span class="term" data-term="certification/extension first posted" tabindex="-1" title="Show definition">certification/extension first posted</span>).</div></li><li class="glossary__item"><button aria-controls="glossary-content-14" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Certification/extension first submitted that met QC criteria</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-14" style="display: none;">The date on which the study sponsor or investigator first submitted a <span class="term" data-term="certification" tabindex="-1" title="Show definition">certification</span> or an <span class="term" data-term="extension request" tabindex="-1" title="Show definition">extension request</span> that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" tabindex="-1" title="Show definition">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit a certification or extension request one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria. Meeting QC criteria for an extension request does not mean that the National Institutes of Health (NIH) has determined that the request demonstrates good cause. The process for review and granting of extension requests by the NIH is being developed.</div></li><li class="glossary__item"><button aria-controls="glossary-content-15" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">City and distance</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-15" style="display: none;">In the search feature, the City field is used to find clinical studies with locations in a specific city. The Distance field is used to find studies with locations within the specified distance from a city in number of miles. For example, if you choose Illinois as the <span class="term" data-term="state" tabindex="-1" title="Show definition">state</span>, identifying "Chicago" as the city and "100 miles" as the distance will find all studies listing a location within 100 miles of Chicago.</div></li><li class="glossary__item"><button aria-controls="glossary-content-16" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Clinical study</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-16" style="display: none;">A research study involving human volunteers (also called participants) that is intended to add to medical knowledge. There are two types of clinical studies: <span class="term" data-term="interventional study (clinical trial)" tabindex="-1" title="Show definition">interventional studies</span> (also called clinical trials) and <span class="term" data-term="observational study" tabindex="-1" title="Show definition">observational studies</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-17" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Clinical trial</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-17" style="display: none;">Another name for an <span class="term" data-term="interventional study (clinical trial)" tabindex="-1" title="Show definition">interventional study</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-18" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">ClinicalTrials.gov identifier (NCT number)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-18" style="display: none;">The unique identification code given to each clinical study upon <span class="term" data-term="registration" tabindex="-1" title="Show definition">registration</span> at ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419).</div></li><li class="glossary__item"><button aria-controls="glossary-content-19" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Collaborator</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-19" style="display: none;">An organization other than the <span class="term" data-term="sponsor" tabindex="-1" title="Show definition">sponsor</span> that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.</div></li><li class="glossary__item"><button aria-controls="glossary-content-20" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Condition/disease</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-20" style="display: none;">The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.</div></li><li class="glossary__item"><button aria-controls="glossary-content-21" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Contact</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-21" style="display: none;">The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.</div></li><li class="glossary__item"><button aria-controls="glossary-content-22" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Country</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-22" style="display: none;">In the search feature, the Country field is used to find clinical studies with locations in a specific country. For example,  if you choose the United States, you can then narrow your search by selecting a <span class="term" data-term="state" tabindex="-1" title="Show definition">state</span> and identifying a <span class="term" data-term="city and distance" tabindex="-1" title="Show definition">city and distance</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-23" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Cross-over assignment</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-23" style="display: none;">A type of <span class="term" data-term="intervention model" tabindex="-1" title="Show definition">intervention model</span> describing a clinical trial in which groups of participants receive two or more interventions in a specific order. For example, two-by-two cross-over assignment involves two groups of participants. One group receives drug A during the initial phase of the trial, followed by drug B during a later phase. The other group receives drug B during the initial phase, followed by drug A. So during the trial, participants "cross over" to the other drug. All participants receive drug A and drug B at some point during the trial but in a different order, depending on the group to which they are assigned.</div></li><li class="glossary__item"><button aria-controls="glossary-content-24" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Data Monitoring Committee (DMC)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-24" style="display: none;">A group of independent scientists who monitor the safety and scientific integrity of a <span class="term" data-term="clinical trial" tabindex="-1" title="Show definition">clinical trial</span>. The DMC can recommend to the sponsor that the trial be stopped if it is not effective, is harming participants, or is unlikely to serve its scientific purpose. Members are chosen based on the scientific skills and knowledge needed to monitor the particular trial. Also called a data safety and monitoring board, or DSMB.</div></li><li class="glossary__item"><button aria-controls="glossary-content-25" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Early Phase 1 (formerly listed as Phase 0)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-25" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="Show definition">phase</span> of research used to describe exploratory trials conducted before traditional <span class="term" data-term="phase 1" tabindex="-1" title="Show definition">phase 1</span> trials to investigate how or whether a drug affects the body. They involve very limited human exposure to the drug and have no therapeutic or diagnostic goals (for example, screening studies, microdose studies).</div></li><li class="glossary__item"><button aria-controls="glossary-content-26" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Eligibility criteria</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-26" style="display: none;">The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both <span class="term" data-term="inclusion criteria" tabindex="-1" title="Show definition">inclusion criteria</span> (which are required for a person to participate in the study) and <span class="term" data-term="exclusion criteria" tabindex="-1" title="Show definition">exclusion criteria</span> (which prevent a person from participating). Types of eligibility criteria include whether a study <span class="term" data-term="accepts healthy volunteers" tabindex="-1" title="Show definition"> accepts healthy volunteers</span>, has <span class="term" data-term="age or age group" tabindex="-1" title="Show definition">age or age group</span> requirements, or is limited by <span class="term" data-term="sex" tabindex="-1" title="Show definition">sex</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-27" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Enrollment</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-27" style="display: none;">The number of participants in a clinical study. The "estimated" enrollment is the target number of participants that the researchers need for the study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-28" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Exclusion criteria</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-28" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="Show definition">eligibility criteria</span>. These are reasons that a person is not allowed to participate in a clinical study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-29" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Expanded access</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-29" style="display: none;">A way for patients with serious diseases or conditions who cannot participate in a clinical trial to gain access to a medical product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="Show definition">U.S. Food and Drug Administration (FDA)</span>. Also called compassionate use.  There are different <span class="term" data-term="expanded access type" tabindex="-1" title="Show definition">expanded access types</span>. <p style="margin-bottom:-.4em;">For more information, see FDA <a href="https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/ucm20041768.htm" style="text-decoration:underline dotted" tabindex="-1" target="_blank">Expanded Access: Information for Patients</a>.</p></div></li><li class="glossary__item"><button aria-controls="glossary-content-30" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Expanded access status</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-30" style="display: none;"><ul><li><strong>Available:</strong> <span class="term" data-term="expanded access" tabindex="-1" title="Show definition">Expanded access</span> is currently available for this investigational treatment, and patients who are not participants in the clinical study may be able to gain access to the drug, biologic, or medical device being studied.</li><li><strong>No longer available:</strong> <span class="term" data-term="expanded access" tabindex="-1" title="Show definition">Expanded access</span> was available for this intervention previously but is not currently available and will not be available in the future.</li><li><strong>Temporarily not available:</strong> <span class="term" data-term="expanded access" tabindex="-1" title="Show definition">Expanded access</span> is not currently available for this intervention but is expected to be available in the future.</li><li><strong>Approved for marketing:</strong> The intervention has been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="Show definition"> U.S. Food and Drug Administration</span> for use by the public.</li></ul></div></li><li class="glossary__item"><button aria-controls="glossary-content-31" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Expanded access type</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-31" style="display: none;">Describes the category of <span class="term" data-term="expanded access" tabindex="-1" title="Show definition">expanded access</span> under <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="Show definition">U.S. Food and Drug Administration (FDA)</span> regulations. There are three types of expanded access: <ul><li><strong>Individual Patients</strong>: Allows a single patient, with a serious disease or condition who cannot participate in a clinical trial, access to a drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="Show definition">FDA</span>. This category also includes access in an emergency situation.</li><li><strong>Intermediate-size Population</strong>: Allows more than one patient (but generally fewer patients than through a Treatment IND/Protocol) access to a drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="Show definition">FDA</span>.  This type of expanded access is used when multiple patients with the same disease or condition seek access to a specific drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="Show definition">FDA</span>.</li><li><strong><a id="treatment-ind" tabindex="-1"></a>Treatment IND/Protocol</strong>: Allows a large, widespread population access to a drug or biological product that has not been approved by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="Show definition">FDA</span>. This type of expanded access can only be provided if the product is already being developed for marketing for the same use as the expanded access use.</li></ul></div></li><li class="glossary__item"><button aria-controls="glossary-content-32" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Experimental arm</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-32" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="Show definition">arm type</span> in which a group of participants receives the <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span> that is the focus of the clinical trial.</div></li><li class="glossary__item"><button aria-controls="glossary-content-33" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Extension request</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-33" style="display: none;">In certain circumstances, a sponsor or investigator may request an extension to delay the standard results submission deadline (generally one year after the <span class="term" data-term="primary completion date" tabindex="-1" title="Show definition">primary completion date</span>). The request for an extension must demonstrate good cause (for example, the need to preserve the scientific integrity of an ongoing <span class="term" data-term="masking" tabindex="-1" title="Show definition">masked</span> trial). All requests must be reviewed and granted by the National Institutes of Health. This process for review and granting of extension requests is being developed. See <a href="https://prsinfo.clinicaltrials.gov/results_definitions.html#DelayResultsType" style="text-decoration:underline dotted" tabindex="-1" target="_blank">Delay Results Type</a> in the Results Data Element definitions for more information.</div></li><li class="glossary__item"><button aria-controls="glossary-content-34" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Factorial assignment</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-34" style="display: none;">A type of <span class="term" data-term="intervention model" tabindex="-1" title="Show definition">intervention model</span> describing a clinical trial in which groups of participants receive one of several combinations of interventions. For example, two-by-two factorial assignment involves four groups of participants. Each group receives one of the following pairs of interventions: (1) drug A and drug B, (2) drug A and a placebo, (3) a placebo and drug B, or (4) a placebo and a placebo. So during the trial, all possible combinations of the two drugs (A and B) and the placebos are given to different groups of participants.</div></li><li class="glossary__item"><button aria-controls="glossary-content-35" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">First posted</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-35" style="display: none;">The date on which the <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> was first available on ClinicalTrials.gov. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.</div></li><li class="glossary__item"><button aria-controls="glossary-content-36" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">First submitted</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-36" style="display: none;">The date on which the study sponsor or investigator first submitted a <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the <span class="term" data-term="first posted" tabindex="-1" title="Show definition">first posted</span> date).</div></li><li class="glossary__item"><button aria-controls="glossary-content-37" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">First submitted that met QC criteria</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-37" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" tabindex="-1" title="Show definition">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class="glossary__item"><button aria-controls="glossary-content-38" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-38" style="display: none;">U.S. Public Law 110-85, which was enacted on September 27, 2007. Section 801 of FDAAA amends Section 402 of the U.S. Public Health Service Act to expand ClinicalTrials.gov and create a clinical study <span class="term" data-term="results database" tabindex="-1" title="Show definition">results database</span>. For more information on FDAAA 801, see the <a href="https://clinicaltrials.gov/ct2/about-site/history" style="text-decoration:underline dotted" tabindex="-1" target="_blank">History, Policies, and Laws</a> page on this site.</div></li><li class="glossary__item"><button aria-controls="glossary-content-39" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Funder type</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-39" style="display: none;">Describes the organization that provides funding or support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting. Organizations listed as <span class="term" data-term="sponsor" tabindex="-1" title="Show definition">sponsors</span> and <span class="term" data-term="collaborator" tabindex="-1" title="Show definition">collaborators</span> for a study are considered the funders of the study. ClinicalTrials.gov refers to four types of funders: <ul><li>U.S. National Institutes of Health</li><li>Other U.S. Federal agencies (for example, Food and Drug Administration, Centers for Disease Control and Prevention, or U.S. Department of Veterans Affairs)</li><li>Industry (for example: pharmaceutical and device companies)</li><li>All others (including individuals, universities, and community-based organizations)</li></ul></div></li><li class="glossary__item"><button aria-controls="glossary-content-40" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Gender-based eligibility</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-40" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="Show definition">eligibility criteria</span> that indicates whether eligibility to participate in a clinical study is based a person's self-representation of gender identity or gender (yes, no). Gender is distinct from <span class="term" data-term="sex" tabindex="-1" title="Show definition">sex</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-41" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Group/cohort</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-41" style="display: none;">A group or subgroup of participants in an <span class="term" data-term="observational study" tabindex="-1" title="Show definition">observational study</span> that is assessed for biomedical or health outcomes.</div></li><li class="glossary__item"><button aria-controls="glossary-content-42" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Human subjects protection review board</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-42" style="display: none;">A group of people who review, approve, and monitor the clinical study's <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span>. Their role is to protect the rights and welfare of people participating in a study (referred to as human research subjects), such as reviewing the <span class="term" data-term="informed consent form (icf)" tabindex="-1" title="Show definition">informed consent form</span>. The group typically includes people with varying backgrounds, including a community member, to make sure that research activities conducted by an organization are completely and adequately reviewed. Also called an institutional review board, or IRB, or an ethics committee.<p>For more information, see <a href="https://clinicaltrials.gov/about-studies/learn#Participating" style="text-decoration:underline dotted" tabindex="-1" target="_blank">Participating in Studies</a> on this site.</p></div></li><li class="glossary__item"><button aria-controls="glossary-content-43" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Inclusion criteria</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-43" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="Show definition">eligibility criteria</span>. These are the reasons that a person is allowed to participate in a clinical study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-44" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Informed consent</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-44" style="display: none;">A process used by researchers to communicate to potential and enrolled participants the risks and potential benefits of participating in a clinical study. <p>For more information, see <a href="https://clinicaltrials.gov/ct2/about-studies/learn#Participating" style="text-decoration:underline dotted" tabindex="-1" target="_blank">Participating in Studies</a> on this site.</p></div></li><li class="glossary__item"><button aria-controls="glossary-content-45" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Informed consent form (ICF)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-45" style="display: none;">The document used in the <span class="term" data-term="informed consent" tabindex="-1" title="Show definition">informed consent</span> or process.</div></li><li class="glossary__item"><button aria-controls="glossary-content-46" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Intervention model</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-46" style="display: none;">The general design of the strategy for assigning interventions to participants in a clinical study. Types of intervention models include: <span class="term" data-term="single group assignment" tabindex="-1" title="Show definition">single group assignment</span>, <span class="term" data-term="parallel assignment" tabindex="-1" title="Show definition">parallel assignment</span>, <span class="term" data-term="cross-over assignment" tabindex="-1" title="Show definition">cross-over assignment</span>, and <span class="term" data-term="factorial assignment" tabindex="-1" title="Show definition">factorial assignment</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-47" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Intervention/treatment</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-47" style="display: none;">A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.</div></li><li class="glossary__item"><button aria-controls="glossary-content-48" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Interventional study (clinical trial)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-48" style="display: none;">A type of <span class="term" data-term="clinical study" tabindex="-1" title="Show definition">clinical study</span> in which participants are assigned to groups that receive one or more <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span> (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. The assignments are determined by the study's <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span>. Participants may receive diagnostic, therapeutic, or other types of interventions.</div></li><li class="glossary__item"><button aria-controls="glossary-content-49" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Investigator</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-49" style="display: none;">A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study <span class="term" data-term="principal investigator (pi)" tabindex="-1" title="Show definition">principal investigator</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-50" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Last update posted</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-50" style="display: none;">The most recent date on which changes to a <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the <span class="term" data-term="last update submitted" tabindex="-1" title="Show definition">last update submitted</span> date) and the last update posted date.</div></li><li class="glossary__item"><button aria-controls="glossary-content-51" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Last update submitted</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-51" style="display: none;">The most recent date on which the study sponsor or investigator submitted changes to a <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> to ClinicalTrials.gov. There is typically a delay of a few days between the last update submitted date and when the date changes are posted on ClinicalTrials.gov (the <span class="term" data-term="last update posted" tabindex="-1" title="Show definition">last update posted</span> date).</div></li><li class="glossary__item"><button aria-controls="glossary-content-52" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Last update submitted that met QC criteria</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-52" style="display: none;">The most recent date on which the study sponsor or investigator submitted changes to a <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> that are consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" tabindex="-1" title="Show definition">quality control (QC) review</span> criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class="glossary__item"><button aria-controls="glossary-content-53" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Last verified</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-53" style="display: none;">The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a <span class="term" data-term="recruitment status" tabindex="-1" title="Show definition">recruitment status</span> of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's <span class="term" data-term="recruitment status" tabindex="-1" title="Show definition">recruitment status</span> is shown as <span class="term" data-term="unknown" tabindex="-1" title="Show definition">unknown</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-54" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Listed location countries</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-54" style="display: none;">Countries in which research facilities for a study are located. A country is listed only once, even if there is more than one facility in the country. The list includes all countries as of the <span class="term" data-term="last update submitted" tabindex="-1" title="Show definition">last update submitted</span> date; any country for which all facilities were removed from the <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> are listed under <span class="term" data-term="removed location countries" tabindex="-1" title="Show definition">removed location countries</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-55" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Location terms</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-55" style="display: none;">In the search feature, the Location terms field is used to narrow a search by location-related terms other than Country, State, and City or distance. For example, you may enter a specific facility name (such as National Institutes of Health Clinical Center) or a part of a facility name (such as Veteran for studies listing Veterans Hospital or Veteran Affairs in the facility name). Note: Not all <span class="term" data-term="study record" tabindex="-1" title="Show definition">study records</span> include this level of detail about locations.</div></li><li class="glossary__item"><button aria-controls="glossary-content-56" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Masking</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-56" style="display: none;">A clinical trial design strategy in which one or more parties involved in the trial, such as the investigator or participants, do not know which participants have been assigned which interventions. Types of masking include: open label, single blind masking, and double-blind masking.</div></li><li class="glossary__item"><button aria-controls="glossary-content-57" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">NCT number</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-57" style="display: none;">A unique identification code given to each clinical study record registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the <span class="term" data-term="clinicaltrials.gov identifier (nct number)" tabindex="-1" title="Show definition">ClinicalTrials.gov identifier</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-58" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">No intervention arm</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-58" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="Show definition">arm type</span> in which a group of participants does not receive any <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span> during the clinical trial.</div></li><li class="glossary__item"><button aria-controls="glossary-content-59" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Observational study</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-59" style="display: none;">A type of <span class="term" data-term="clinical study" tabindex="-1" title="Show definition">clinical study</span> in which participants are identified as belonging to study groups and are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to a specific <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">interventions/treatment</span>.<p>A <span class="term" data-term="patient registry" tabindex="-1" title="Show definition">patient registry</span> is a type of observational study.</p></div></li><li class="glossary__item"><button aria-controls="glossary-content-60" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Observational study model</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-60" style="display: none;">The general design of the strategy for identifying and following up with participants during an <span class="term" data-term="observational study" tabindex="-1" title="Show definition">observational study</span>. Types of observational study models include cohort, case-control, case-only, case-cross-over, ecologic or community studies, family-based, and other.</div></li><li class="glossary__item"><button aria-controls="glossary-content-61" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Other adverse event</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-61" style="display: none;">An <span class="term" data-term="adverse event" tabindex="-1" title="Show definition">adverse event</span> that is not a <span class="term" data-term="serious adverse event" tabindex="-1" title="Show definition">serious adverse event</span>, meaning that it does not result in death, is not life-threatening, does not require inpatient hospitalization or extend a current hospital stay, does not result in an ongoing or significant incapacity or interfere substantially with normal life functions, and does not cause a congenital anomaly or birth defect; it also does not put the participant in danger and does not require medical or surgical intervention to prevent one of the results listed above.</div></li><li class="glossary__item"><button aria-controls="glossary-content-62" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Other study IDs</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-62" style="display: none;">Identifiers or ID numbers other than the <span class="term" data-term="nct number" tabindex="-1" title="Show definition">NCT number</span> that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.</div></li><li class="glossary__item"><button aria-controls="glossary-content-63" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Other terms</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-63" style="display: none;">In the search feature, the Other terms field is used to narrow a search. For example, you may enter the name of a drug or the NCT number of a clinical study to limit the search to <span class="term" data-term="study record" tabindex="-1" title="Show definition">study records</span> that contain these words.</div></li><li class="glossary__item"><button aria-controls="glossary-content-64" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Outcome measure</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-64" style="display: none;">For <span class="term" data-term="clinical trial" tabindex="-1" title="Show definition">clinical trials</span>, a planned measurement described in the protocol that is used to determine the effect of an <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span> on participants. For <span class="term" data-term="observational study" tabindex="-1" title="Show definition">observational studies</span>, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include <span class="term" data-term="primary outcome measure" tabindex="-1" title="Show definition">primary outcome measure</span> and <span class="term" data-term="secondary outcome measure" tabindex="-1" title="Show definition">secondary outcome measure</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-65" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Parallel assignment</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-65" style="display: none;">A type of <span class="term" data-term="intervention model" tabindex="-1" title="Show definition">intervention model</span> describing a clinical trial in which two or more groups of participants receive different interventions. For example, a two-arm parallel assignment involves two groups of participants. One group receives drug A, and the other group receives drug B. So during the trial, participants in one group receive drug A "in parallel" to participants in the other group, who receive drug B.</div></li><li class="glossary__item"><button aria-controls="glossary-content-66" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Participant flow</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-66" style="display: none;">A summary of the progress of participants through each stage of a clinical study, by study <span class="term" data-term="arm" tabindex="-1" title="Show definition">arm</span> or <span class="term" data-term="group/cohort" tabindex="-1" title="Show definition">group/cohort</span>. This includes the number of participants who started, completed, and dropped out of the study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-67" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Patient registry</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-67" style="display: none;">A type of <span class="term" data-term="observational study" tabindex="-1" title="Show definition">observational study</span> that collects information about patients' medical conditions and/or treatments to better understand how a condition or treatment affects patients in the real world.</div></li><li class="glossary__item"><button aria-controls="glossary-content-68" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Phase</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-68" style="display: none;">The stage of a clinical trial studying a drug or biological product, based on definitions developed by the <span class="term" data-term="u.s. food and drug administration (fda)" tabindex="-1" title="Show definition">U.S. Food and Drug Administration (FDA)</span>. The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: <span class="term" data-term="early phase 1 (formerly listed as phase 0)" tabindex="-1" title="Show definition">Early Phase 1 (formerly listed as Phase 0)</span>, <span class="term" data-term="phase 1" tabindex="-1" title="Show definition">Phase 1</span>, <span class="term" data-term="phase 2" tabindex="-1" title="Show definition">Phase 2</span>, <span class="term" data-term="phase 3" tabindex="-1" title="Show definition">Phase 3</span>, and <span class="term" data-term="phase 4" tabindex="-1" title="Show definition">Phase 4</span>. <span class="term" data-term="phase not applicable" tabindex="-1" title="Show definition">Not Applicable</span> is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.</div></li><li class="glossary__item"><button aria-controls="glossary-content-69" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Phase 1</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-69" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="Show definition">phase</span> of research to describe clinical trials that focus on the safety of a drug. They are usually conducted with healthy volunteers, and the goal is to determine the drug's most frequent and <span class="term" data-term="serious adverse event" tabindex="-1" title="Show definition">serious adverse events</span> and, often, how the drug is broken down and excreted by the body. These trials usually involve a small number of participants.</div></li><li class="glossary__item"><button aria-controls="glossary-content-70" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Phase 2</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-70" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="Show definition">phase</span> of research to describe clinical trials that gather preliminary data on whether a drug works in people who have a certain <span class="term" data-term="condition/disease" tabindex="-1" title="Show definition">condition/disease</span> (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a <span class="term" data-term="placebo" tabindex="-1" title="Show definition">placebo</span>) or a different drug. Safety continues to be evaluated, and short-term <span class="term" data-term="adverse event" tabindex="-1" title="Show definition">adverse events</span> are studied.</div></li><li class="glossary__item"><button aria-controls="glossary-content-71" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Phase 3</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-71" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="Show definition">phase</span> of research to describe clinical trials that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.</div></li><li class="glossary__item"><button aria-controls="glossary-content-72" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Phase 4</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-72" style="display: none;">A <span class="term" data-term="phase" tabindex="-1" title="Show definition">phase</span> of research to describe clinical trials occurring after FDA has approved a drug for marketing. They include postmarket requirement and commitment studies that are required of or agreed to by the study sponsor. These trials gather additional information about a drug's safety, efficacy, or optimal use.</div></li><li class="glossary__item"><button aria-controls="glossary-content-73" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Phase Not Applicable</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-73" style="display: none;">Describes trials without FDA-defined <span class="term" data-term="phase" tabindex="-1" title="Show definition">phases</span>, including trials of devices or behavioral interventions.</div></li><li class="glossary__item"><button aria-controls="glossary-content-74" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Placebo</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-74" style="display: none;">An inactive substance or treatment that looks the same as, and is given in the same way as, an active drug or <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span> being studied.</div></li><li class="glossary__item"><button aria-controls="glossary-content-75" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Placebo comparator arm</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-75" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="Show definition">arm type</span> in which a group of participants receives a <span class="term" data-term="placebo" tabindex="-1" title="Show definition">placebo</span> during a clinical trial.</div></li><li class="glossary__item"><button aria-controls="glossary-content-76" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Primary completion date</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-76" style="display: none;">The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the <span class="term" data-term="primary outcome measure" tabindex="-1" title="Show definition">primary outcome measure</span>. Whether the clinical study ended according to the <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span> or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "estimated" primary completion date is the date that the researchers think will be the primary completion date for the study. </div></li><li class="glossary__item"><button aria-controls="glossary-content-77" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Primary outcome measure</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-77" style="display: none;">In a clinical study's <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span>, the planned outcome measure that is the most important for evaluating the effect of an <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span>. Most clinical studies have one primary outcome measure, but some have more than one.</div></li><li class="glossary__item"><button aria-controls="glossary-content-78" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Primary purpose</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-78" style="display: none;">The main reason for the <span class="term" data-term="clinical trial" tabindex="-1" title="Show definition">clinical trial</span>. The types of primary purpose are: treatment, prevention, diagnostic, supportive care, screening, health services research, basic science, and other.</div></li><li class="glossary__item"><button aria-controls="glossary-content-79" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Principal investigator (PI)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-79" style="display: none;">The person who is responsible for the scientific and technical direction of the entire clinical study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-80" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Protocol</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-80" style="display: none;">The written description of a clinical study. It includes the study's objectives, design, and methods. It may also include relevant scientific background and statistical information.</div></li><li class="glossary__item"><button aria-controls="glossary-content-81" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Quality control (QC) review</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-81" style="display: none;">National Library of Medicine (NLM) staff perform a limited review of submitted <span class="term" data-term="study record" tabindex="-1" title="Show definition">study records</span> for apparent errors, deficiencies, or inconsistencies. NLM staff identify potential major and advisory issues and provide comments directly to the study sponsor or investigator. Major issues identified in QC review must be addressed or corrected (see <span class="term" data-term="first submitted that met qc criteria" tabindex="-1" title="Show definition">First submitted that met QC criteria</span> and <span class="term" data-term="results first submitted that met qc criteria" tabindex="-1" title="Show definition">Results first submitted that met QC criteria</span>). Advisory issues are suggestions to help improve the clarity of the record. NLM staff do not verify the scientific validity or relevance of the submitted information. The study sponsor or investigator is responsible for ensuring that the studies follow all applicable laws and regulations.</div></li><li class="glossary__item"><button aria-controls="glossary-content-82" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Randomized allocation</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-82" style="display: none;">A type of <span class="term" data-term="allocation" tabindex="-1" title="Show definition">allocation</span> strategy in which participants are assigned to the <span class="term" data-term="arm" tabindex="-1" title="Show definition">arms</span> of a clinical trial by chance.</div></li><li class="glossary__item"><button aria-controls="glossary-content-83" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Recruitment status</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-83" style="display: none;"><ul><li><strong>Not yet recruiting:</strong> The study has not started recruiting participants.</li><li><strong>Recruiting:</strong> The study is currently recruiting participants.</li><li><strong>Enrolling by invitation:</strong> The study is selecting its participants from a population, or group of people, decided on by the researchers in advance. These studies are not open to everyone who meets the eligibility criteria but only to people in that particular population, who are specifically invited to participate.</li><li><strong>Active, not recruiting:</strong> The study is ongoing, and participants are receiving an intervention or being examined, but potential participants are not currently being recruited or enrolled.</li><li><strong>Suspended:</strong> The study has stopped early but may start again.</li><li><strong>Terminated:</strong> The study has stopped early and will not start again. Participants are no longer being examined or treated.</li><li><strong>Completed:</strong> The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).</li><li><strong>Withdrawn:</strong> The study stopped early, before enrolling its first participant.</li><li><strong>Unknown:</strong> A study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been <span class="term" data-term="last verified" tabindex="-1" title="Show definition">last verified</span> within the past 2 years.</li></ul></div></li><li class="glossary__item"><button aria-controls="glossary-content-84" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Registration</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-84" style="display: none;">The process of submitting and updating summary information about a clinical study and its <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span>, from its beginning to end, to a structured, public Web-based <span class="term" data-term="study registry" tabindex="-1" title="Show definition">study registry</span> that is accessible to the public, such as ClinicalTrials.gov.</div></li><li class="glossary__item"><button aria-controls="glossary-content-85" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Removed location countries</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-85" style="display: none;">Countries that appeared under <span class="term" data-term="listed location countries" tabindex="-1" title="Show definition">listed location countries</span> but were removed from the <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> by the sponsor or investigator.</div></li><li class="glossary__item"><button aria-controls="glossary-content-86" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Reporting group</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-86" style="display: none;">A grouping of participants in a clinical study that is used for summarizing the data collected during the study. This grouping may be the same as or different from a study arm or group.</div></li><li class="glossary__item"><button aria-controls="glossary-content-87" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Responsible party</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-87" style="display: none;">The person responsible for submitting information about a clinical study to ClinicalTrials.gov and updating that information. Usually the study sponsor or investigator.</div></li><li class="glossary__item"><button aria-controls="glossary-content-88" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Results database</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-88" style="display: none;">A structured online system, such as the ClinicalTrials.gov results database, that provides the public with access to registration and summary results information for completed or terminated clinical studies. A study with results available on ClinicalTrials.gov is described as having the results "posted." <p><strong>Note:</strong> The ClinicalTrials.gov results database became available in September 2008. Older studies are unlikely to have results available in the database.</p></div></li><li class="glossary__item"><button aria-controls="glossary-content-89" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Results delayed</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-89" style="display: none;">Indicates that the sponsor or investigator submitted a <span class="term" data-term="certification" tabindex="-1" title="Show definition">certification</span> or <span class="term" data-term="extension request" tabindex="-1" title="Show definition">extension request</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-90" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Results first posted</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-90" style="display: none;">The date on which summary results information was first available on ClinicalTrials.gov. There is typically a delay between the date the study sponsor or investigator first submits summary results information (the <span class="term" data-term="results first submitted" tabindex="-1" title="Show definition">results first submitted</span> date) and the results first posted date.</div></li><li class="glossary__item"><button aria-controls="glossary-content-91" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Results first submitted</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-91" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> with summary results information. There is typically a delay between the results first submitted date and when summary results information becomes available on ClinicalTrials.gov (the <span class="term" data-term="results first posted" tabindex="-1" title="Show definition">results first posted</span> date).</div></li><li class="glossary__item"><button aria-controls="glossary-content-92" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Results first submitted that met QC criteria</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-92" style="display: none;">The date on which the study sponsor or investigator first submits a <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> with summary results information that is consistent with National Library of Medicine (NLM) <span class="term" data-term="quality control (qc) review" tabindex="-1" title="Show definition">quality control (QC) review</span> criteria. The sponsor or investigator may need to revise and submit results information one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.</div></li><li class="glossary__item"><button aria-controls="glossary-content-93" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Results returned after quality control review</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-93" style="display: none;">The date on which the National Library of Medicine provided <span class="term" data-term="quality control (qc) review" tabindex="-1" title="Show definition">quality control (QC) review</span> comments to the study sponsor or investigator. The sponsor or investigator must address major issues identified in the review comments. If there is a date listed for results returned after quality control review, but there is not a subsequent date listed for <span class="term" data-term="results submitted to clinicaltrials.gov" tabindex="-1" title="Show definition">results submitted to ClinicalTrials.gov</span>, this means that the submission is pending changes by the sponsor or investigator.</div></li><li class="glossary__item"><button aria-controls="glossary-content-94" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Results submitted to ClinicalTrials.gov</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-94" style="display: none;">The date on which the study sponsor or investigator first submitted summary results information or submitted changes to summary results information. Submissions with changes are typically in response to <span class="term" data-term="quality control (qc) review" tabindex="-1" title="Show definition">quality control (QC) review</span> comments from the National Library of Medicine (NLM). If there is a date listed for results submitted to ClinicalTrials.gov, but there is not a subsequent date listed for <span class="term" data-term="results returned after quality control review" tabindex="-1" title="Show definition">results returned after quality control review</span>, this means that the submission is pending review by NLM.</div></li><li class="glossary__item"><button aria-controls="glossary-content-95" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Secondary outcome measure</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-95" style="display: none;">In a clinical study's <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span>, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.</div></li><li class="glossary__item"><button aria-controls="glossary-content-96" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Serious adverse event</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-96" style="display: none;">An <span class="term" data-term="adverse event" tabindex="-1" title="Show definition">adverse event</span> that results in death, is life-threatening, requires inpatient hospitalization or extends a current hospital stay, results in an ongoing or significant incapacity or interferes substantially with normal life functions, or causes a congenital anomaly or birth defect. Medical events that do not result in death, are not life-threatening, or do not require hospitalization may be considered serious adverse events if they put the participant in danger or require medical or surgical intervention to prevent one of the results listed above.</div></li><li class="glossary__item"><button aria-controls="glossary-content-97" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Sex</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-97" style="display: none;">A type of <span class="term" data-term="eligibility criteria" tabindex="-1" title="Show definition">eligibility criteria</span> that indicates the sex of people who may participate in a clinical study (all, female, male). Sex is a person's classification as female or male based on biological distinctions. Sex is distinct from <span class="term" data-term="gender-based eligibility" tabindex="-1" title="Show definition">gender-based eligibility</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-98" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Sham comparator arm</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-98" style="display: none;">An <span class="term" data-term="arm type" tabindex="-1" title="Show definition">arm type</span> in which a group of participants receives a procedure or device that appears to be the same as the actual procedure or device being studied but does not contain active processes or components.</div></li><li class="glossary__item"><button aria-controls="glossary-content-99" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Single group assignment</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-99" style="display: none;">A type of <span class="term" data-term="intervention model" tabindex="-1" title="Show definition">intervention model</span> describing a clinical trial in which all participants receive the same intervention/treatment.</div></li><li class="glossary__item"><button aria-controls="glossary-content-100" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Sort studies by</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-100" style="display: none;">In Advanced Search, the Sort studies by option is used to change the order of studies listed on the Search Results page. You can sort by Relevance or Newest First: <ul><li>Relevance: Studies that best match your search terms appear higher in the search results list. This is the default display for all searches.</li><li>Newest First: Studies with the most recent <span class="term" data-term="first posted" tabindex="-1" title="Show definition">First posted</span> dates appear higher in the search results list.</li></ul></div></li><li class="glossary__item"><button aria-controls="glossary-content-101" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Sponsor</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-101" style="display: none;">The organization or person who initiates the study and who has authority and control over the study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-102" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">State</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-102" style="display: none;">In the search feature, the State field is used to find clinical studies with locations in a specific state within the United States. If you choose United States in the <span class="term" data-term="country" tabindex="-1" title="Show definition">Country</span> field, you can search for studies with locations in a specific state.</div></li><li class="glossary__item"><button aria-controls="glossary-content-103" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Statistical analysis plan (SAP)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-103" style="display: none;">The written description of the statistical considerations and methods for analyzing the data collected in the <span class="term" data-term="clinical study" tabindex="-1" title="Show definition">clinical study</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-104" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Status</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-104" style="display: none;">Indicates the current <span class="term" data-term="recruitment status" tabindex="-1" title="Show definition">recruitment status</span> or the <span class="term" data-term="expanded access status" tabindex="-1" title="Show definition">expanded access status</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-105" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study completion date</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-105" style="display: none;">The date on which the last participant in a clinical study was examined or received an <span class="term" data-term="intervention/treatment" tabindex="-1" title="Show definition">intervention/treatment</span> to collect final data for the <span class="term" data-term="primary outcome measure" tabindex="-1" title="Show definition">primary outcome measures</span>, <span class="term" data-term="secondary outcome measure" tabindex="-1" title="Show definition">secondary outcome measures</span>, and <span class="term" data-term="adverse event" tabindex="-1" title="Show definition">adverse events</span> (that is, the last participant's last visit). The "estimated" study completion date is the date that the researchers think will be the study completion date.</div></li><li class="glossary__item"><button aria-controls="glossary-content-106" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study design</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-106" style="display: none;">The investigative methods and strategies used in the clinical study.</div></li><li class="glossary__item"><button aria-controls="glossary-content-107" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study documents</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-107" style="display: none;">Refers to the type of documents that the study sponsor or principal investigator may add to their <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span>. These include a study <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span>, <span class="term" data-term="statistical analysis plan (sap)" tabindex="-1" title="Show definition">statistical analysis plan</span>, and <span class="term" data-term="informed consent form (icf)" tabindex="-1" title="Show definition">informed consent form</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-108" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study IDs</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-108" style="display: none;">Identifiers that are assigned to a clinical study by the study's <span class="term" data-term="sponsor" tabindex="-1" title="Show definition">sponsor</span>, funders, or others. They include unique identifiers from other trial <span class="term" data-term="study registry" tabindex="-1" title="Show definition">study registries</span> and National Institutes of Health grant numbers. Note: ClinicalTrials.gov assigns a unique identification code to each clinical study registered on ClinicalTrials.gov. Also called the <span class="term" data-term="nct number" tabindex="-1" title="Show definition">NCT number</span>, the format is "NCT" followed by an 8-digit number (for example, NCT00000419).</div></li><li class="glossary__item"><button aria-controls="glossary-content-109" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study record</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-109" style="display: none;">An entry on ClinicalTrials.gov that contains a summary of a clinical study's protocol information, including the <span class="term" data-term="recruitment status" tabindex="-1" title="Show definition">recruitment status</span>; eligibility criteria; contact information; and, in some cases, summary results. Each study record is assigned a ClinicalTrials.gov identifier, or <span class="term" data-term="nct number" tabindex="-1" title="Show definition">NCT number</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-110" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study registry</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-110" style="display: none;">A structured online system, such as ClinicalTrials.gov, that provides the public with access to summary information about ongoing and completed clinical studies.</div></li><li class="glossary__item"><button aria-controls="glossary-content-111" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study results</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-111" style="display: none;">A <span class="term" data-term="study record" tabindex="-1" title="Show definition">study record</span> that includes the summary results posted in the ClinicalTrials.gov <span class="term" data-term="results database" tabindex="-1" title="Show definition">results database</span>. Summary results information includes <span class="term" data-term="participant flow" tabindex="-1" title="Show definition">participant flow</span>, <span class="term" data-term="baseline characteristics" tabindex="-1" title="Show definition">baseline characteristics</span>, <span class="term" data-term="outcome measure" tabindex="-1" title="Show definition">outcome measures</span>, and <span class="term" data-term="adverse event" tabindex="-1" title="Show definition">adverse events</span> (including <span class="term" data-term="serious adverse event" tabindex="-1" title="Show definition">serious adverse events</span>).</div></li><li class="glossary__item"><button aria-controls="glossary-content-112" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study start date</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-112" style="display: none;">The actual date on which the first participant was enrolled in a clinical study. The "estimated" study start date is the date that the researchers think will be the study start date.</div></li><li class="glossary__item"><button aria-controls="glossary-content-113" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Study type</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-113" style="display: none;">Describes the nature of a <span class="term" data-term="clinical study" tabindex="-1" title="Show definition">clinical study</span>. Study types include <span class="term" data-term="interventional study (clinical trial)" tabindex="-1" title="Show definition">interventional studies</span> (also called clinical trials), <span class="term" data-term="observational study" tabindex="-1" title="Show definition">observational studies</span> (including <span class="term" data-term="patient registry" tabindex="-1" title="Show definition">patient registries</span>), and <span class="term" data-term="expanded access" tabindex="-1" title="Show definition">expanded access</span>.</div></li><li class="glossary__item"><button aria-controls="glossary-content-114" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Submitted date</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-114" style="display: none;">The date on which the study sponsor or investigator submitted a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria.</div></li><li class="glossary__item"><button aria-controls="glossary-content-115" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Title</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-115" style="display: none;">The official title of a <span class="term" data-term="protocol" tabindex="-1" title="Show definition">protocol</span> used to identify a clinical study or a short title written in language intended for the lay public.</div></li><li class="glossary__item"><button aria-controls="glossary-content-116" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Title acronym</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-116" style="display: none;">The acronym or initials used to identify a clinical study (not all studies have one). For example, the title acronym for the Women's Health Initiative is "WHI."</div></li><li class="glossary__item"><button aria-controls="glossary-content-117" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">U.S. Agency for Healthcare Research and Quality (AHRQ)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-117" style="display: none;">An agency within the U.S. Department of Health and Human Services. AHRQ's mission is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work within the U.S. Department of Health and Human Services and with other partners to make sure that the evidence is understood and used.</div></li><li class="glossary__item"><button aria-controls="glossary-content-118" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">U.S. Food and Drug Administration (FDA)</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-118" style="display: none;">An agency within the U.S. Department of Health and Human Services. The FDA is responsible for protecting the public health by making sure that human and veterinary drugs, vaccines and other biological products, medical devices, the Nation's food supply, cosmetics, dietary supplements, and products that give off radiation are safe, effective, and secure.</div></li><li class="glossary__item"><button aria-controls="glossary-content-119" aria-expanded="false" class="data-glossary-term glossary__term" tabindex="-1">Unknown</button><div aria-hidden="true" class="glossary__definition" id="glossary-content-119" style="display: none;">A type of <span class="term" data-term="recruitment status" tabindex="-1" title="Show definition">recruitment status</span>. It identifies a study on ClinicalTrials.gov whose last known status was recruiting; not yet recruiting; or active, not recruiting but that has passed its completion date, and the status has not been verified within the past 2 years. Studies with an unknown status are considered closed studies.</div></li></ul>
</div>
</div>
<div id="skip"> <a href="https://clinicaltrials.gov/#main-content">Skip to Main Content</a> </div>
<div class="ct-dim" id="workingDim">
<div class="ct-workingBox" id="workingIndicator" style="text-align:center;vertical-align:middle;">
<img alt="Working..." height="48" src="https://clinicaltrials.gov/ct2/html/images/working.gif"/>
</div>
</div>
<script src="https://clinicaltrials.gov/ct2/html/js/working.js" type="text/javascript"></script><noscript></noscript>
<div id="wrapper">
<div class="ct-inner_wrapper"> <a href="https://clinicaltrials.gov/ct2/home" style="float:left;border-bottom-width:0;min-width:200px;width:30%;"><img alt="ClinicalTrials.gov" src="https://clinicaltrials.gov/ct2/html/images/ct.gov-nlm-nih-logo.png"/></a>
<div class="w3-hide-medium w3-hide-large" id="hamburger" style="float:right;border-width:0;display:block;margin-left:1em;padding:4px;" title="Show menus">
<img alt="ClinicalTrials.gov Menu" onclick="$('#global-nav-popupMenu').toggle();" src="https://clinicaltrials.gov/ct2/html/images/hamburgerMenuIcon.png" style="max-width:30px;cursor:pointer;"/>
</div>
<div class="w3-hide-medium w3-hide-large w3-modal w3-center" id="global-nav-popupMenu" onclick="$('#global-nav-popupMenu').hide();" style="display:none;"> <div class="w3-modal-content" id="global-nav-popupMenu-content">
<div class="w3-container">
<span class="w3-closebtn" onclick="$('#global-nav-popupMenu').hide();"></span>
<ul class="sf-menu sf-vertical sf-js-enabled">
<li class="first"><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/search/index">Find Studies<img alt="Find Studies Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li><a href="https://clinicaltrials.gov/ct2/home">New Search</a></li>
<li><a href="https://clinicaltrials.gov/ct2/search/advanced">Advanced Search</a></li>
<li><a href="https://clinicaltrials.gov/ct2/search/browse?brwse=cond_cat">See Studies by Topic</a></li>
<li><a href="https://clinicaltrials.gov/ct2/search/map">See Studies on Map</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/help/how-find/index">How to Search</a></li>
<li><a href="https://clinicaltrials.gov/ct2/help/how-use-search-results">How to Use Search Results</a></li>
<li><a href="https://clinicaltrials.gov/ct2/help/how-find/find-study-results">How to Find Results of Studies</a></li>
<li><a href="https://clinicaltrials.gov/ct2/help/how-read-study">How to Read a Study Record</a></li>
</ul>
</li>
<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/about-studies">About Studies<img alt="About Studies Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li><a href="https://clinicaltrials.gov/ct2/about-studies/learn">Learn About Studies</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-studies/other-sites">Other Sites About Studies</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-studies/glossary">Glossary of Common Site Terms</a></li>
</ul>
</li>
<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/manage-recs">Submit Studies<img alt="Submit Studies Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/background">Why Should I Register and Submit Results?</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/fdaaa">FDAAA 801 and the Final Rule</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/manage-recs/how-apply">How to Apply for an Account</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-register">How to Register Your Study</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-edit">How to Edit Your Study Record</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-report">How to Submit Your Results</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/manage-recs/faq">Frequently Asked Questions</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/resources">Support Materials</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/present">Training Materials</a></li>
</ul>
</li>
<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/resources">Resources<img alt="Resources Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li><a href="https://clinicaltrials.gov/ct2/resources/pubs">Selected Publications</a></li>
<li><a href="https://clinicaltrials.gov/ct2/resources/alert">Clinical Alerts and Advisories</a></li>
<li><a href="https://clinicaltrials.gov/ct2/resources/rss">RSS Feeds</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/resources/trends">Trends, Charts, and Maps</a></li>
<li><a href="https://clinicaltrials.gov/ct2/resources/download">Downloading Content for Analysis</a></li>
</ul>
</li>
<li class="last"><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/about-site">About Site<img alt="About Site Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/about-site/new">What's New</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/background">ClinicalTrials.gov Background</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/results">About the Results Database</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/history">History, Policies, and Laws</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/for-media">Media/Press Resources</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/about-site/link-to">Linking to This Site</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">Disclaimer</a></li>
</ul>
</li>
</ul>
</div>
</div>
</div>
<div class="w3-hide-small" style="float:right;margin-top:1.5%;">
<ul class="sf-menu sf-vertical sf-js-enabled">
<li class="first"><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/search/index">Find Studies<img alt="Find Studies Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li><a href="https://clinicaltrials.gov/ct2/home">New Search</a></li>
<li><a href="https://clinicaltrials.gov/ct2/search/advanced">Advanced Search</a></li>
<li><a href="https://clinicaltrials.gov/ct2/search/browse?brwse=cond_cat">See Studies by Topic</a></li>
<li><a href="https://clinicaltrials.gov/ct2/search/map">See Studies on Map</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/help/how-find/index">How to Search</a></li>
<li><a href="https://clinicaltrials.gov/ct2/help/how-use-search-results">How to Use Search Results</a></li>
<li><a href="https://clinicaltrials.gov/ct2/help/how-find/find-study-results">How to Find Results of Studies</a></li>
<li><a href="https://clinicaltrials.gov/ct2/help/how-read-study">How to Read a Study Record</a></li>
</ul>
</li>
<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/about-studies">About Studies<img alt="About Studies Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li><a href="https://clinicaltrials.gov/ct2/about-studies/learn">Learn About Studies</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-studies/other-sites">Other Sites About Studies</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-studies/glossary">Glossary of Common Site Terms</a></li>
</ul>
</li>
<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/manage-recs">Submit Studies<img alt="Submit Studies Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/background">Why Should I Register and Submit Results?</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/fdaaa">FDAAA 801 and the Final Rule</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/manage-recs/how-apply">How to Apply for an Account</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-register">How to Register Your Study</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-edit">How to Edit Your Study Record</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/how-report">How to Submit Your Results</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/manage-recs/faq">Frequently Asked Questions</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/resources">Support Materials</a></li>
<li><a href="https://clinicaltrials.gov/ct2/manage-recs/present">Training Materials</a></li>
</ul>
</li>
<li><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/resources">Resources<img alt="Resources Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li><a href="https://clinicaltrials.gov/ct2/resources/pubs">Selected Publications</a></li>
<li><a href="https://clinicaltrials.gov/ct2/resources/alert">Clinical Alerts and Advisories</a></li>
<li><a href="https://clinicaltrials.gov/ct2/resources/rss">RSS Feeds</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/resources/trends">Trends, Charts, and Maps</a></li>
<li><a href="https://clinicaltrials.gov/ct2/resources/download">Downloading Content for Analysis</a></li>
</ul>
</li>
<li class="last"><a class="sf-with-ul" href="https://clinicaltrials.gov/ct2/about-site">About Site<img alt="About Site Menu" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/></a>
<ul style="display: none;">
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/about-site/new">What's New</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/background">ClinicalTrials.gov Background</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/results">About the Results Database</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/history">History, Policies, and Laws</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/for-media">Media/Press Resources</a></li>
<li class="new-group"><a href="https://clinicaltrials.gov/ct2/about-site/link-to">Linking to This Site</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">Disclaimer</a></li>
</ul>
</li>
</ul>
<div style="clear:both;"></div>
</div>
<div style="clear:both;"></div>
</div>
<div class="ct-outer_breadcrumb w3-container">
<div id="breadcrumb">
<ul class="ct-horz-list w3-left">
<li><a href="https://clinicaltrials.gov/ct2/home">Home</a></li>
<li><a href="https://clinicaltrials.gov/ct2/results">Search Results</a></li>
<li>Study Record Detail</li>
</ul>
<div class="w3-right" id="savedStudies">
<div id="cart" onclick="location.href=('/ct2/results'+cartToURL()); showWorking();" style="cursor: pointer; display: none;">
<button class="ct-savedStudiesEnabled" id="open-cart-link" onclick="location.href=('/ct2/results'+cartToURL()); showWorking();" title="Show previously saved studies." type="button">Saved Studies (0)</button>
</div>
</div>
<script src="https://clinicaltrials.gov/ct2/html/js/cart.js?v=27" type="text/javascript"></script><noscript></noscript>
<script type="text/javascript">
	$(document).ready(function(){
		$("input#saved").prop( 'checked', (inCart("NCT01040910")>=0));
	});
</script>
<div class="w3-right" style="margin-right: 1em;">
<label for="saved" title="Add or Remove this study in the Saved Studies list"><input id="saved" name="NCT01040910" onchange="updateCart('NCT01040910');" style="margin-left:1em;" type="checkbox"/> Save this study </label>
</div>
<div class="w3-modal" id="maxSavedStudies-popup" onclick="$('#maxSavedStudies-popup').hide();" style="cursor:pointer;border:2px groove">
<div class="w3-modal-content" id="maxSavedStudies-popup-content">
<div class="w3-display-container" style="border:1px solid #ccc;background-color:#eee;">
<form>
<div class="w3-center" style="font-size:large;font-weight:bold;padding:3ex 1.5em;">
<img alt="Maximum Saved Studies Reached" src="https://clinicaltrials.gov/ct2/html/images/warning.png" style="max-width:1.0rem;cursor:pointer;"/>
<b>Warning</b>
<div style="margin-top:1ex;margin-bottom:0.5ex;">You have reached the maximum number of saved studies (100).</div>
<div>Please remove one or more studies before adding more.</div>
</div>
<div class="w3-center" style="padding-bottom:1.5ex">
<input class="ct-searchButton" onclick="$('#maxSavedStudies-popup').hide();" style="opacity:1.0;font-weight:bold;font-size:inherit;padding:1.1ex 1em;" title="Close this dialog" type="button" value="Close"/>
</div>
</form>
</div>
</div>
</div>
</div>
</div>
<div style="clear:both;"></div>
<div id="main-content" tabindex="-1">
<div class="tr-indent2">
<h1 class="tr-h1 ct-sans-serif tr-solo_record">Cannabis for Inflammatory Bowel Disease</h1>
<div class="row">
<div class="tr-column tr-left">
<div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;">
<table>
<tbody><tr>
<td style="width:5%">
<img alt="" src="https://clinicaltrials.gov/ct2/html/images/warning.png" style="width:1.3em;"/>
</td>
<td>
              The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
                            Read our <a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">disclaimer</a> for details.
            </td>
</tr>
</tbody></table>
</div> </div>
<!--
  <div style="float:right;margin-right:4em">ClinicalTrials.gov Identifier: NCT01040910</div>
-->
<div class="tr-column tr-right">
<table style="width:90%">
<tbody><tr><td>ClinicalTrials.gov Identifier: NCT01040910</td>
</tr>
<tr><td>
<div class="tr-status tr-unknown-recruiting-colors">
<span class="term" data-term="recruitment status" style="display:inline;" tabindex="0" title="Show definition">Recruitment Status <i aria-hidden="true" class="fa fa-info-circle term" data-term="recruitment status" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> : Unknown
                            <div class="tr-status-details" title="The Last Verified date is the most recent date on which all of a clinical study's information on ClinicalTrials.gov was confirmed as accurate and current by the responsible party.">
<span style="color:#0000cc">Verified December 2011</span> by NAFTALI TIMNA, Meir Medical Center. <br/> Recruitment status was: Recruiting
                
  <div style="font-size:inherit">
<span class="term" data-term="first posted" style="display:inline;" tabindex="0" title="Show definition">First Posted <i aria-hidden="true" class="fa fa-info-circle term" data-term="first posted" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> : December 30, 2009</div>
<div style="font-size:inherit">
<span class="term" data-term="last update posted" style="display:inline;" tabindex="0" title="Show definition">Last Update Posted <i aria-hidden="true" class="fa fa-info-circle term" data-term="last update posted" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> : December 16, 2011</div>
</div>
</div>
</td>
</tr>
</tbody></table>
</div>
</div>
<div class="tr-info-title">Sponsor:</div>
<div class="tr-info-text" id="sponsor"> Meir Medical Center </div>
<div class="tr-info-title">Information provided by (Responsible Party):</div>
<div class="tr-info-text" id="responsibleparty">NAFTALI TIMNA, Meir Medical Center</div>
</div>
<br/>
<div id="tabs">
<ul id="tab-links">
<li class="current" id="full-text">Study Details     </li>
<li id="tabular"><a href="https://clinicaltrials.gov/ct2/show/record/NCT01040910">Tabular View</a></li>
<li id="results"><a href="https://clinicaltrials.gov/ct2/show/results/NCT01040910">Results Submitted</a></li>
<li id="disclaimer"><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false" title="Disclaimer - opens new window">Disclaimer</a></li>
<li id="howtoread"><a href="https://clinicaltrials.gov/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false" title="How to Read a Study Record - opens new window">How to Read a Study Record</a></li>
</ul>
</div> <!--
<div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"> </div>
-->
<div id="tab-body">
<div class="tr-indent2" style="background-color:white;">
<div class="tr-indent1" style="margin-top:1ex">
<div class="tr-subsection">
<div class="ct-header2"><a id="studydesc"></a>Study Description</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Goto
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="https://clinicaltrials.gov/#wrapper">Top of Page</a>
<a href="https://clinicaltrials.gov/#studydesc">Study Description</a>
<a href="https://clinicaltrials.gov/#studydesign">Study Design</a>
<a href="https://clinicaltrials.gov/#armgroup">Arms and Interventions</a>
<a href="https://clinicaltrials.gov/#outcomemeasures">Outcome Measures</a>
<a href="https://clinicaltrials.gov/#eligibility">Eligibility Criteria</a>
<a href="https://clinicaltrials.gov/#contactlocation">Contacts and Locations</a>
<a href="https://clinicaltrials.gov/#moreinfo">More Information</a>
</div>
</div>
</div>
<div class="tr-indent2" style="margin-top:2ex">
<div class="ct-body3">Brief Summary:</div>
<div class="ct-body3 tr-indent2"><p style="margin-top:1ex; margin-bottom:1ex;">Background: The marijuana plant Cannabis has been used for centuries in the medicinal treatment of many disorders and is still the subject of medical research and public debate. Cannabinoids have been purported to alleviate a variety of neurological conditions such as MS-related symptoms including spasticity, pain, tremor and bladder dysfunction. Other neurological conditions like chronic intractable pain, dystonic movement disorders and Tourette's Syndrome were all reported to be alleviated by cannabis use. Cannabis has been used to treat anorexia in AIDS and cancer patients. In gastroenterology cannabis has been used to treat symptoms and diseases including anorexia, emesis, abdominal pain, gastroenteritis, diarrhoea, intestinal inflammation and diabetic gastroparesis.</p>
<p style="margin-top:0ex; margin-bottom:1ex;">Cannabinoids have also a profound anti inflammatory effect, mainly through the CB2 receptor. Cell mediated immunity may be impaired in chronic marijuana users. And a potent anti-inflammatory effect of cannabis was observed in rats . Studying the functional roles of the endocannabinoid system in immune modulation reveals that there are no major immune events which do not involve the endocannabinoid system. Cannabinoids shift the balance of pro-inflammatory cytokines and anti-inflammatory cytokines towards the T-helper cell type 2 profiles (Th2 phenotype), and suppress cell-mediated immunity whereas humoral immunity may be enhanced. They are therefore used for various inflammatory conditions including rheumatoid arthritis and asthma. In a mouse model of colitis cannabinoids were found to ameliorate inflammation and there are many anecdotal reports about the effect of cannabis in inflammatory bowel disease. However, there are no methodical reports of the effect of cannabis on inflammatory bowel disease. The aim of the proposed study is to examine in a double blind placebo controlled fashion the effect of smoking cannabis on disease activity in patients with IBD.</p></div><br/>
<table border="1" class="ct-data_table tr-data_table" style="margin:auto;width:80%;">
<tbody><tr style="text-align:left;">
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="condition/disease" style="display:inline;" tabindex="0" title="Show definition">Condition or disease <i aria-hidden="true" class="fa fa-info-circle term" data-term="condition/disease" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> </th>
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="intervention/treatment" style="display:inline;" tabindex="0" title="Show definition">Intervention/treatment <i aria-hidden="true" class="fa fa-info-circle term" data-term="intervention/treatment" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> </th>
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="phase" style="display:inline;" tabindex="0" title="Show definition">Phase <i aria-hidden="true" class="fa fa-info-circle term" data-term="phase" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> </th>
</tr>
<tr style="text-align:left;vertical-align:top;">
<td class="ct-body3">
<span style="display:block;margin-bottom:1ex;">Crohn's Disease</span>
<span style="display:block;margin-bottom:1ex;">Ulcerative Colitis</span>
</td>
<td class="ct-body3">
<span style="display:block;margin-bottom:1ex;">Drug: smoking of cannabis</span>
<span style="display:block;margin-bottom:1ex;">Drug: smoking cigarettes with placebo</span>
</td>
<td class="ct-body3" style="white-space:nowrap;">
<span style="display:block;margin-bottom:1ex;">Phase 1</span>
<span style="display:block;margin-bottom:1ex;">Phase 2</span>
</td>
</tr>
</tbody></table>
<br/>
<a id="desc"></a>
</div>
<div class="tr-subsection">
<div class="ct-header2"><a id="studydesign"></a>Study Design</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Goto
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="https://clinicaltrials.gov/#wrapper">Top of Page</a>
<a href="https://clinicaltrials.gov/#studydesc">Study Description</a>
<a href="https://clinicaltrials.gov/#studydesign">Study Design</a>
<a href="https://clinicaltrials.gov/#armgroup">Arms and Interventions</a>
<a href="https://clinicaltrials.gov/#outcomemeasures">Outcome Measures</a>
<a href="https://clinicaltrials.gov/#eligibility">Eligibility Criteria</a>
<a href="https://clinicaltrials.gov/#contactlocation">Contacts and Locations</a>
<a href="https://clinicaltrials.gov/#moreinfo">More Information</a>
</div>
</div>
</div>
<p>
</p><table class="ct-layout_table" style="margin-bottom:2ex;">
<caption>Layout table for study information</caption>
<thead>
<tr>
<th id="studyInfoColTitle"></th>
<th id="studyInfoColData"></th>
</tr>
</thead>
<tbody><tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">
<span class="term" data-term="study type" style="display:inline;" tabindex="0" title="Show definition">Study Type <i aria-hidden="true" class="fa fa-info-circle term" data-term="study type" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">
        Interventional
                (Clinical Trial)
                
        
      </td>
</tr>
<tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">Estimated
<span class="term" data-term="enrollment" style="display:inline;" tabindex="0" title="Show definition">Enrollment <i aria-hidden="true" class="fa fa-info-circle term" data-term="enrollment" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">20 participants</td>
</tr>
<tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">Allocation:</td>
<td headers="studyInfoColData" style="padding-left:1em">Randomized</td>
</tr>
<tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">Intervention Model:</td>
<td headers="studyInfoColData" style="padding-left:1em">Parallel Assignment</td>
</tr>
<tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">Masking:</td>
<td headers="studyInfoColData" style="padding-left:1em"> Triple (Participant, Care Provider, Investigator)</td>
</tr>
<tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">Primary Purpose:</td>
<td headers="studyInfoColData" style="padding-left:1em"> Treatment</td>
</tr>
<tr style="vertical-align:top;">
<!--
      <td headers="studyInfoColTitle" style="padding-top:2ex;text-align:right;white-space:nowrap;">Official Title:</td>
-->
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">Official Title:</td>
<td headers="studyInfoColData" style="padding-left:1em;">A Double Blind Placebo Controlled Study of Cannabis Smoking in Inflammatory Bowel Disease</td>
</tr>
<tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;"> <span class="term" data-term="study start date" style="display:inline;" tabindex="0" title="Show definition">Study Start Date <i aria-hidden="true" class="fa fa-info-circle term" data-term="study start date" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">January 2010</td>
</tr>
<tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">  Estimated <span class="term" data-term="primary completion date" style="display:inline;" tabindex="0" title="Show definition">Primary Completion Date <i aria-hidden="true" class="fa fa-info-circle term" data-term="primary completion date" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">June 2012</td>
</tr>
<tr style="vertical-align:top;">
<td headers="studyInfoColTitle" style="text-align:right;white-space:nowrap;">  Estimated <span class="term" data-term="study completion date" style="display:inline;" tabindex="0" title="Show definition">Study Completion Date <i aria-hidden="true" class="fa fa-info-circle term" data-term="study completion date" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> :</td>
<td headers="studyInfoColData" style="padding-left:1em">July 2012</td>
</tr>
</tbody></table>
<p>
</p><div class="tr-indent2" style="background: linear-gradient(#FFFFFF, #EEEEEE); width:60%">
<div class="usa-alert usa-alert-warning">
<strong>Resource links provided by the National Library of Medicine</strong>
<img alt="" src="https://clinicaltrials.gov/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;"/>
<p>
</p><p>
</p><div style="margin-bottom:2ex">
<a class="tr-study-link" href="https://ghr.nlm.nih.gov/" onclick="openNewWindow('https://ghr.nlm.nih.gov/'); return false" title="Genetics Home Reference">Genetics Home Reference</a> related topics:
    	    	    	<a class="tr-study-link" href="https://ghr.nlm.nih.gov/condition/crohn-disease" onclick="openNewWindow('https://ghr.nlm.nih.gov/condition/crohn-disease'); return false" style="margin-left:0.5em;" title="Crohndisease at Genetics Home Reference">Crohndisease</a>
<a class="tr-study-link" href="https://ghr.nlm.nih.gov/condition/ulcerative-colitis" onclick="openNewWindow('https://ghr.nlm.nih.gov/condition/ulcerative-colitis'); return false" style="margin-left:0.5em;" title="Ulcerativecolitis at Genetics Home Reference">Ulcerativecolitis</a>
</div>
<div style="margin-bottom:2ex;">
<a class="tr-study-link" href="https://medlineplus.gov/" onclick="openNewWindow('https://medlineplus.gov/'); return false" title="MedlinePlus">MedlinePlus</a> related topics:
    	    	    	<a class="tr-study-link" href="https://medlineplus.gov/marijuana.html" onclick="openNewWindow('https://medlineplus.gov/marijuana.html'); return false" style="margin-left:0.5em;" title="Marijuana at MedlinePlus">Marijuana</a>
<a class="tr-study-link" href="https://medlineplus.gov/smoking.html" onclick="openNewWindow('https://medlineplus.gov/smoking.html'); return false" style="margin-left:0.5em;" title="Smoking at MedlinePlus">Smoking</a>
</div>
<!-- Commented out RoPR
  -->
<div style="margin-bottom:2ex;">
<a class="tr-study-link" href="https://clinicaltrials.gov/ct2/info/fdalinks" onclick="openNewWindow('/ct2/info/fdalinks'); return false" title="Show FDA resources page">U.S. FDA Resources</a>
</div>
</div>
</div>
<br/>
</div>
<div class="tr-subsection">
<div class="ct-header2"><a id="armgroup"></a>Arms and Interventions</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Goto
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="https://clinicaltrials.gov/#wrapper">Top of Page</a>
<a href="https://clinicaltrials.gov/#studydesc">Study Description</a>
<a href="https://clinicaltrials.gov/#studydesign">Study Design</a>
<a href="https://clinicaltrials.gov/#armgroup">Arms and Interventions</a>
<a href="https://clinicaltrials.gov/#outcomemeasures">Outcome Measures</a>
<a href="https://clinicaltrials.gov/#eligibility">Eligibility Criteria</a>
<a href="https://clinicaltrials.gov/#contactlocation">Contacts and Locations</a>
<a href="https://clinicaltrials.gov/#moreinfo">More Information</a>
</div>
</div>
</div>
<div style="padding-left:.8em; padding-right:1.2em;text-align:left;">
<p>
</p><table class="ct-data_table tr-data_table" style="padding:5px;width:100%;border-width:1px;">
<tbody><tr style="text-align:left;">
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="arm" style="display:inline;" tabindex="0" title="Show definition">Arm <i aria-hidden="true" class="fa fa-info-circle term" data-term="arm" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> </th>
<th class="ct-header3 tr-pale_banner_color">
<span class="term" data-term="intervention/treatment" style="display:inline;" tabindex="0" title="Show definition">Intervention/treatment <i aria-hidden="true" class="fa fa-info-circle term" data-term="intervention/treatment" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> </th>
</tr>
<tr style="text-align:left;vertical-align:top;">
<td class="ct-body3">
          Active Comparator: cannabis smoking for IBD
<div class="tr-indent2" style="margin-top:0.5ex">patients with active disease receiving active cannabis for smoking</div>
</td>
<td class="ct-body3">
                      Drug: smoking of cannabis
<div class="tr-indent2" style="margin-top:0.5ex">smoking of cannabis, 2 cigarettes a day, equivalent to about 50 mg THC</div><br/>
</td>
</tr>
<tr style="text-align:left;vertical-align:top;">
<td class="ct-body3">
          Placebo Comparator: patients smoking non active cannabis
<div class="tr-indent2" style="margin-top:0.5ex">patients with active disease receiving cannabis from which active ingredients have been chemically removed</div>
</td>
<td class="ct-body3">
                      Drug: smoking cigarettes with placebo
<div class="tr-indent2" style="margin-top:0.5ex">smoking cigarettes with cannabis that was chemically treated so that most active ingredients were removed</div><br/>
</td>
</tr>
</tbody></table>
</div>
<br/>
<br/>
<div class="tr-subsection">
<div class="ct-header2"><a id="outcomemeasures"></a>Outcome Measures</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Goto
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="https://clinicaltrials.gov/#wrapper">Top of Page</a>
<a href="https://clinicaltrials.gov/#studydesc">Study Description</a>
<a href="https://clinicaltrials.gov/#studydesign">Study Design</a>
<a href="https://clinicaltrials.gov/#armgroup">Arms and Interventions</a>
<a href="https://clinicaltrials.gov/#outcomemeasures">Outcome Measures</a>
<a href="https://clinicaltrials.gov/#eligibility">Eligibility Criteria</a>
<a href="https://clinicaltrials.gov/#contactlocation">Contacts and Locations</a>
<a href="https://clinicaltrials.gov/#moreinfo">More Information</a>
</div>
</div>
</div>
<br/>
<div class="tr-indent3" style="margin-right:1em;">
<div class="ct-body3">
<span class="term" data-term="primary outcome measure" style="display:inline;" tabindex="0" title="Show definition">Primary Outcome Measures <i aria-hidden="true" class="fa fa-info-circle term" data-term="primary outcome measure" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> :
      <ol style="margin-top:1ex; margin-bottom:1ex;">
<li style="margin-top:0.7ex;">reduction of CDAI by 70 points [TimeFrame:8 weeks]<br/>
</li></ol>
</div>
<br/>
<div class="ct-body3" style="margin-right:1em;">
<span class="term" data-term="secondary outcome measure" style="display:inline;" tabindex="0" title="Show definition">Secondary Outcome Measures <i aria-hidden="true" class="fa fa-info-circle term" data-term="secondary outcome measure" style="border-bottom-style:none;" tabindex="0" title="Show definition"></i></span> :
      <ol style="margin-top:1ex; margin-bottom:1ex;">
<li style="margin-top:0.7ex;">adverse events due to cannabis smoking [TimeFrame:8 weeks]<br/>
</li><li style="margin-top:0.7ex;">change in quality of life before and at the end of study [TimeFrame:8 weeks]<br/>
</li><li style="margin-top:0.7ex;">change in IL-10. IL-2. TGF beta [TimeFrame:week 0 and week 8]<br/>
</li></ol>
</div>
<br/>
</div>
<div class="tr-indent1" style="margin-top:3ex; border:1px solid white">
<div class="tr-subsection">
<div class="ct-header2"><a id="eligibility"></a>Eligibility Criteria</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Goto
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="https://clinicaltrials.gov/#wrapper">Top of Page</a>
<a href="https://clinicaltrials.gov/#studydesc">Study Description</a>
<a href="https://clinicaltrials.gov/#studydesign">Study Design</a>
<a href="https://clinicaltrials.gov/#armgroup">Arms and Interventions</a>
<a href="https://clinicaltrials.gov/#outcomemeasures">Outcome Measures</a>
<a href="https://clinicaltrials.gov/#eligibility">Eligibility Criteria</a>
<a href="https://clinicaltrials.gov/#contactlocation">Contacts and Locations</a>
<a href="https://clinicaltrials.gov/#moreinfo">More Information</a>
</div>
</div>
</div>
<br/>
<p>
</p><div class="tr-indent2" style="background: linear-gradient(#FFFFFF, #EEEEEE); width:80%">
<div class="usa-alert usa-alert-warning">
<strong>Information from the National Library of Medicine</strong>
<img alt="" src="https://clinicaltrials.gov/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;"/>
<p>
</p><p>
<em>Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, <a href="https://clinicaltrials.gov/ct2/about-studies/learn" title="Learn About Clinical Studies"><u>Learn About Clinical Studies.</u></a>
</em>
</p></div>
</div>
<br/>
<div class="tr-indent2">
<table class="ct-layout_table">
<caption>Layout table for eligibility information</caption>
<thead>
<tr>
<th id="elgType"></th>
<th id="elgData"></th>
</tr>
</thead>
<tbody><tr>
<td headers="elgType" style="text-align:right;white-space:nowrap;">Ages Eligible for Study:  </td>
<td headers="elgData" style="padding-left:1em">20 Years to 70 Years  (Adult, Older Adult)</td>
</tr>
<tr>
<td headers="elgType" style="text-align:right;white-space:nowrap;">Sexes Eligible for Study:  </td>
<td headers="elgData" style="padding-left:1em">All</td>
</tr>
<tr>
<td headers="elgType" style="text-align:right;white-space:nowrap;">Accepts Healthy Volunteers:  </td>
<td headers="elgData" style="padding-left:1em">No</td>
</tr>
</tbody></table>
<div class="ct-header3" style="margin-top:2ex">Criteria</div>
<div class="tr-indent2"><p style="margin-top:1ex; margin-bottom:1ex;">Inclusion Criteria:</p>
<ol style="margin-top:1ex; margin-bottom:1ex;">
<li style="margin-top:0.7ex;">Patients with a diagnosis IBD at least 3 months before recruitment will be eligible to the study.</li>
<li style="margin-top:0.7ex;">Patients with active disease who are resistant to either 5 ASA, steroids or immunomodulators, or who can not receive those drugs due to adverse reactions will be offered the possibility of smoking cannabis at a dose of two cigarettes a day which will contain either regular cannabis or pre treated cannabis as placebo.</li>
<li style="margin-top:0.7ex;">Disease activity index of either CDAI of more then 200 in Crohn's disease or Mayo score above 3 in UC.</li>
<li style="margin-top:0.7ex;">Age above 20.</li>
</ol>
<p style="margin-top:0ex; margin-bottom:1ex;">Exclusion Criteria:</p>
<ol style="margin-top:1ex; margin-bottom:1ex;">
<li style="margin-top:0.7ex;">Patients with a known mental disorder</li>
<li style="margin-top:0.7ex;">Patients who are deemed to be at a high risk of abuse or addiction to the study drug.</li>
<li style="margin-top:0.7ex;">Pregnant women</li>
<li style="margin-top:0.7ex;">Patients who are sensitive to any of the ingredients of the study medication.</li>
<li style="margin-top:0.7ex;">Patients who are unable to give informed consent.</li>
<li style="margin-top:0.7ex;">Patients who may need surgery in the near future.</li>
</ol></div>
</div>
</div>
<a id="contacts"></a>
<div class="tr-indent1" style="margin-top:3ex">
<div class="tr-subsection">
<div class="ct-header2"><a id="contactlocation"></a>Contacts and Locations</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Goto
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="https://clinicaltrials.gov/#wrapper">Top of Page</a>
<a href="https://clinicaltrials.gov/#studydesc">Study Description</a>
<a href="https://clinicaltrials.gov/#studydesign">Study Design</a>
<a href="https://clinicaltrials.gov/#armgroup">Arms and Interventions</a>
<a href="https://clinicaltrials.gov/#outcomemeasures">Outcome Measures</a>
<a href="https://clinicaltrials.gov/#eligibility">Eligibility Criteria</a>
<a href="https://clinicaltrials.gov/#contactlocation">Contacts and Locations</a>
<a href="https://clinicaltrials.gov/#moreinfo">More Information</a>
</div>
</div>
</div>
<br/>
<div class="tr-indent2" style="margin-top:2ex">
<!--
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. 
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. 
For general information, see <a href="/ct2/about-studies/learn" target="def_win" onClick="openNewWindow('/ct2/about-studies/learn'); return false;" title="Learn About Clinical Studies - opens new window"><u>Learn About Clinical Studies.</u></a>
<br/>
-->
<div style="background: linear-gradient(#FFFFFF, #EEEEEE); width:80%">
<div class="usa-alert usa-alert-warning">
<strong>Information from the National Library of Medicine</strong>
<img alt="" src="https://clinicaltrials.gov/ct2/html/images/NIH_NLM_ABRV_BLK_4.png" style="width:5em; float:right;"/>
<p>
</p><p>
<em>
    To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
    </em>
</p><p>
<em>
    Please refer to this study by its ClinicalTrials.gov identifier (NCT number): <strong>NCT01040910</strong>
</em>
</p></div>
</div>
<br/>
<div class="ct-header3" style="margin-top:2ex">Contacts</div>
<div class="tr-table_cover">
<table class="ct-layout_table tr-indent2">
<caption>Layout table for location contacts</caption>
<thead>
<tr>
<th id="contactName" style="visibility:hidden"></th>
<th id="contactPhone" style="visibility:hidden"></th>
<th id="contactEmail" style="visibility:hidden"></th>
<th id="contactAddress" style="visibility:hidden"></th>
</tr>
</thead>
<tbody><tr>
<td headers="contactName" style="padding:1ex 1em 0px 0px;white-space:nowrap;">Contact: Timna Naftali, MD</td>
<td headers="contactPhone" style="padding:1ex 1em 0px 0px;white-space:nowrap;">972-9-7472580 ext 1054</td>
<td headers="contactEmail" style="padding:1ex 1em 0px 0px;white-space:nowrap;"><a href="https://clinicaltrials.gov/ct2/show/NCT01040910/mailto:naftalit%40clalit.org.il?subject=NCT01040910, cannabis1, Cannabis for Inflammatory Bowel Disease">naftalit@clalit.org.il</a></td>
<td headers="contactAddress"></td>
</tr>
<tr>
<td headers="contactName" style="padding:1ex 1em 0px 0px;white-space:nowrap;">Contact: Fred Konikoff, Professor</td>
<td headers="contactPhone" style="padding:1ex 1em 0px 0px;white-space:nowrap;">972-9-7472580 ext 2525</td>
<td headers="contactEmail" style="padding:1ex 1em 0px 0px;white-space:nowrap;"><a href="https://clinicaltrials.gov/ct2/show/NCT01040910/mailto:fred.konikoff%40clalit.org.il?subject=NCT01040910, cannabis1, Cannabis for Inflammatory Bowel Disease">fred.konikoff@clalit.org.il</a></td>
<td headers="contactAddress"></td>
</tr>
</tbody></table>
</div>
<br/>
<a id="locn"></a>
<div class="ct-header3" style="margin-top:2ex">Locations</div>
<div class="tr-table_cover">
<table class="ct-layout_table tr-indent2">
<caption>Layout table for location information</caption>
<thead>
<tr>
<th id="locName"></th>
<th id="locStatus"></th>
</tr>
</thead>
<tbody><tr><td class="ct-header3" colspan="2" style="padding-top:2ex;white-space:nowrap;">Israel</td></tr>
<tr>
<td headers="locName" style="padding:1ex 1em 0px 2em;white-space:nowrap;">Meir hospital</td>
<td class="ct-header3" headers="locStatus" style="padding:1ex 0px 0px 2em;white-space:nowrap;">Recruiting</td>
</tr>
<tr><td colspan="2" style="padding-left:4em;white-space:nowrap;">Kefar Saba, Israel, 44281  </td></tr>
<tr><td colspan="2" style="padding-left:4em">Contact: Timna Naftali, MD  972-9-7472580 ext 1054  <a href="https://clinicaltrials.gov/ct2/show/NCT01040910/mailto:timna.naftali%40clalit.org.il?subject=NCT01040910, cannabis1, Cannabis for Inflammatory Bowel Disease">timna.naftali@clalit.org.il</a>  </td></tr>
<tr><td colspan="2" style="padding-left:4em">Contact: Fred Konikoff, professor  972-9-7472580 ext 2525  <a href="https://clinicaltrials.gov/ct2/show/NCT01040910/mailto:fred.konikoff%40clalit.org.il?subject=NCT01040910, cannabis1, Cannabis for Inflammatory Bowel Disease">fred.konikoff@clalit.org.il</a>  </td></tr>
<tr>
<td headers="locName" style="padding:1ex 1em 0px 2em;white-space:nowrap;">Meir Medical center</td>
<td class="ct-header3" headers="locStatus" style="padding:1ex 0px 0px 2em;white-space:nowrap;">Recruiting</td>
</tr>
<tr><td colspan="2" style="padding-left:4em;white-space:nowrap;">Kfar Saba, Israel  </td></tr>
<tr><td colspan="2" style="padding-left:4em">Contact: Timna Naftali, MD  +97297471054  <a href="https://clinicaltrials.gov/ct2/show/NCT01040910/mailto:timna.naftali%40clalit.org.il?subject=NCT01040910, cannabis1, Cannabis for Inflammatory Bowel Disease">timna.naftali@clalit.org.il</a>  </td></tr>
<tr><td colspan="2" style="padding-left:4em">Contact: Orly Mor  +97297471017  <a href="https://clinicaltrials.gov/ct2/show/NCT01040910/mailto:orly.mor%40clalit.org.il?subject=NCT01040910, cannabis1, Cannabis for Inflammatory Bowel Disease">orly.mor@clalit.org.il</a>  </td></tr>
<tr><td colspan="2" style="padding-left:4em">Principal Investigator: Timna Naftali, MD      </td></tr>
</tbody></table>
</div>
<div class="ct-header3" style="margin-top:2ex">Sponsors and Collaborators</div>
<div class="tr-indent2" style="margin-top:1ex">Meir Medical Center</div>
<div class="ct-header3" style="margin-top:2ex">Investigators</div>
<div class="tr-table_cover">
<table class="ct-layout_table tr-indent2">
<caption>Layout table for investigator information</caption>
<thead>
<tr>
<th id="role" style="visibility:hidden"></th>
<th id="name" style="visibility:hidden"></th>
<th id="affiliation" style="visibility:hidden"></th>
<th id="address" style="visibility:hidden"></th>
</tr>
</thead>
<tbody><tr>
<td headers="role" style="padding:1ex 1em 0px 0px;white-space:nowrap;">Study Chair:</td>
<td headers="name" style="padding:1ex 1em 0px 0px;white-space:nowrap;">Fred Konikoff, professor</td>
<td headers="affiliation" style="padding:1ex 1em 0px 0px;white-space:nowrap;">Sackler school of medicine Tel Aviv university</td>
<td headers="address"></td>
</tr>
<tr>
<td headers="role" style="padding:1ex 1em 0px 0px;white-space:nowrap;">Principal Investigator:</td>
<td headers="name" style="padding:1ex 1em 0px 0px;white-space:nowrap;">Timna Naftali</td>
<td headers="affiliation" style="padding:1ex 1em 0px 0px;white-space:nowrap;">Meir Medical Center</td>
<td headers="address"></td>
</tr>
</tbody></table>
</div>
</div>
</div>
<div class="tr-indent1" style="margin-top:3ex; border:1px solid white">
<div class="tr-subsection">
<div class="ct-header2"><a id="moreinfo"></a>More Information</div>
<div class="tr-underline"></div>
<div class="tr-dropdown" style="padding-right:10em">
Goto
<button class="tr-dropbtn" style="font-weight:bold; font-size:14px">
<img alt="sections" src="https://clinicaltrials.gov/ct2/html/images/pulldown.png"/>
</button>
<div class="tr-dropdown-content">
<a href="https://clinicaltrials.gov/#wrapper">Top of Page</a>
<a href="https://clinicaltrials.gov/#studydesc">Study Description</a>
<a href="https://clinicaltrials.gov/#studydesign">Study Design</a>
<a href="https://clinicaltrials.gov/#armgroup">Arms and Interventions</a>
<a href="https://clinicaltrials.gov/#outcomemeasures">Outcome Measures</a>
<a href="https://clinicaltrials.gov/#eligibility">Eligibility Criteria</a>
<a href="https://clinicaltrials.gov/#contactlocation">Contacts and Locations</a>
<a href="https://clinicaltrials.gov/#moreinfo">More Information</a>
</div>
</div>
</div>
<div class="tr-indent2">
<br/>
<span class="ct-header3">Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):</span>
<div class="tr-indent2">
<div style="margin-top:2ex">
<a href="https://clinicaltrials.gov/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0Rcg4JFgFnA6h9Ei4L3BUgWwNG0it." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0Rcg4JFgFnA6h9Ei4L3BUgWwNG0it.'); return false" title="Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol. 2013 Oct;11(10):1276-1280.e1. doi: 10.1016/j.cgh.2013.04.034. Epub 2013 May 4.">Naftali T, Bar-Lev Schleider L, Dotan I, Lansky EP, Sklerovsky Benjaminov F, Konikoff FM. Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol. 2013 Oct;11(10):1276-1280.e1. doi: 10.1016/j.cgh.2013.04.034. Epub 2013 May 4.</a>
</div>
</div>
<br/>
<table class="ct-layout_table" style="margin-top:1ex;">
<caption>Layout table for additonal information</caption>
<thead>
<tr>
<th id="colTitle1"></th>
<th id="colData1"></th>
</tr>
</thead>
<tbody><tr style="vertical-align:top;">
<td headers="colTitle1" style="white-space:nowrap;">Responsible Party:</td>
<td headers="colData1" style="padding-left:1em">NAFTALI TIMNA, MD, Meir Medical Center</td>
</tr>
<tr style="vertical-align:top;">
<td headers="colTitle1" style="white-space:nowrap;">ClinicalTrials.gov Identifier:</td>
<td headers="colData1" style="padding-left:1em">
<a class="tr-study-link" href="https://clinicaltrials.gov/show/NCT01040910" title="Current version of study NCT01040910 on ClinicalTrials.gov">NCT01040910</a>  
        <a class="tr-study-link" href="https://clinicaltrials.gov/ct2/archive/NCT01040910" onclick="openNewWindow('/ct2/archive/NCT01040910'); return false;" title="Historical versions of study NCT01040910 on ClinicalTrials.gov Archive Site">History of Changes</a>
</td>
</tr>
<tr style="vertical-align:top;">
<td headers="colTitle1" style="white-space:nowrap;">Other Study ID Numbers:</td>
<td headers="colData1" style="padding-left:1em">
                                    cannabis1 <br/>
</td>
</tr>
<tr style="vertical-align:top;">
<td headers="colTitle1" style="white-space:nowrap;">First Posted:</td>
<td headers="colData1" style="padding-left:1em">December 30, 2009
          
          <a class="tr-study-link" href="https://clinicaltrials.gov/ct2/keydates/NCT01040910" onclick="openNewWindow('/ct2/keydates/NCT01040910'); return false;" title="View key record dates for NCT01040910">Key Record Dates</a>
</td>
</tr>
<tr style="vertical-align:top;">
<td headers="colTitle1" style="white-space:nowrap;">Last Update Posted:</td>
<td headers="colData1" style="padding-left:1em">December 16, 2011
      </td>
</tr>
<tr style="vertical-align:top;">
<td headers="colTitle1" style="white-space:nowrap;">Last Verified:</td>
<td headers="colData1" style="padding-left:1em">December 2011
      </td>
</tr>
</tbody></table>
<br/>
		  	Keywords provided by NAFTALI TIMNA, Meir Medical Center:
		<div class="tr-indent3">
<table class="ct-layout_table" style="width:100%;">
<thead>
<tr>
<th id="keywordCol1" style="width:50%;"></th>
<th id="keywordCol2" style="width:50%;"></th>
</tr>
</thead>
<tbody><tr style="vertical-align:top;">
<td headers="keywordCol1">
	          	          cannabis<br/>
	          	          Crohn's disease<br/>
	          	          Ulcerative colitis<br/>
	          	          IBD<br/>
</td>
<td></td>
</tr>
</tbody></table>
</div>
<br/>
  Additional relevant MeSH terms:
  <div class="tr-indent3">
<table class="ct-layout_table" style="width:100%;">
<caption>Layout table for MeSH terms</caption>
<thead>
<tr>
<th id="meshTermCol1" style="width:50%;"></th>
<th id="meshTermCol2" style="width:50%;"></th>
</tr>
</thead>
<tbody><tr style="vertical-align:top;">
<td headers="meshTermCol1">
                    Crohn Disease<br/>
                    Colitis<br/>
                    Ulcer<br/>
                    Colitis, Ulcerative<br/>
                    Intestinal Diseases<br/>
                    Inflammatory Bowel Diseases<br/>
                    Marijuana Abuse<br/>
                    Gastroenteritis<br/>
</td>
<td headers="meshTermCol1" style="padding-left:1em">
                    Gastrointestinal Diseases<br/>
                    Digestive System Diseases<br/>
                    Colonic Diseases<br/>
                    Pathologic Processes<br/>
                    Substance-Related Disorders<br/>
                    Chemically-Induced Disorders<br/>
                    Mental Disorders<br/>
</td>
</tr>
</tbody></table>
</div>
<br/>
<!--
    <span class="ct-body3">ClinicalTrials.gov processed this record on July 12, 2019</span><br/>
  -->
<br/>
</div>
</div>
<div id="to-top"><a href="https://clinicaltrials.gov/#wrapper">To Top</a></div>
<div style="clear:both;"></div>
</div>
</div>
</div>
<div> <div id="for-footer">
<ul class="ct-horz-list">
<li style="border-left:0;"><a href="https://clinicaltrials.gov/ct2/help/for-patient">For Patients and Families</a></li>
<li><a href="https://clinicaltrials.gov/ct2/help/for-researcher">For Researchers</a></li>
<li><a href="https://clinicaltrials.gov/ct2/help/for-manager">For Study Record Managers</a></li>
</ul>
</div>
</div>
<div id="footer-menu">
<ul class="ct-horz-list">
<li><a href="https://clinicaltrials.gov/ct2/home">Home</a></li>
<li><a href="https://clinicaltrials.gov/ct2/resources/rss">RSS Feeds</a></li>
<li><a href="https://clinicaltrials.gov/ct2/sitemap">Site Map</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions">Terms and Conditions</a></li>
<li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">Disclaimer</a></li>
<li><a href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01040910" onclick="openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT01040910'); return false">Customer Support</a></li>
</ul>
</div>
</div>
<div id="fine-print">
<ul class="ct-horz-list">
<li><a href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false" title="NLM copyright information - opens new window">Copyright</a></li>
<li><a href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false" title="NLM privacy policy - opens new window">Privacy</a></li>
<li><a href="https://clinicaltrials.gov/ct2/accessibility" title="NLM Accessibility">Accessibility</a></li>
<li><a href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false" title="NLM viewers and players - opens new window">Viewers and Players</a></li>
<li><a href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false" title="NIH Freedom of Information Act office - opens new window">Freedom of Information Act</a></li>
<li><a href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false" title="USA.gov - opens new window">USA.gov</a></li>
</ul>
<ul class="ct-horz-list">
<li><a href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false" title="U.S. National Library of Medicine - opens new window">U.S. National Library of Medicine</a></li>
<li><a href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false" title="U.S. National Institutes of Health - opens new window">U.S. National Institutes of Health</a></li>
<li><a href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false" title="U.S. Department of Health and Human Services - opens new window">
            U.S. Department of Health and Human Services</a></li>
</ul>
</div>
<script type="text/javascript">__ncbi_sg_gaMode="clinicaltrials"</script>
<script src="https://clinicaltrials.gov/ct2/html/js/instrumentNCBIBaseJS.min.js?v=1" type="text/javascript"></script><script async="1" src="https://www.google-analytics.com/analytics.js"></script><noscript></noscript>
<script src="https://clinicaltrials.gov/ct2/html/js/main-glossary.js" type="text/javascript"></script><noscript></noscript>
<ul class="print-log"><li></li></ul><script src="https://zn7whwrcrmbs9xwyd-nlmenterprise.siteintercept.qualtrics.com/WRSiteInterceptEngine/?Q_ZID=ZN_7WHWRcRMBs9xWYd&amp;t=1563096133581" type="text/javascript"></script></body></html>